Protocatechuic aldehyde protects against experimental sepsis in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Basic & Clinical Pharmacology & Toxicology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1742-7843.2011.00827.xPMID 22050905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IN VIVO AND IN VITRO EFFECTS OF THE ANTICOAGULANT, THROMBOMODULIN, ON THE INFLAMMATORY RESPONSE IN RODENT MODELS

  2010cited by this paper
• PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis

  2009cited by this paper
• Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis.

  2009cited by this paper
• ROSMARINIC ACID PROTECTS AGAINST EXPERIMENTAL SEPSIS BY INHIBITING PROINFLAMMATORY FACTOR RELEASE AND AMELIORATING HEMODYNAMICS

  2009cited by this paper
• Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis

  2009cited by this paper
• Effect of Cornuside on Experimental Sepsis

  2009cited by this paper
• &agr;-LIPOIC ACID AS A POTENTIAL TARGET FOR THE TREATMENT OF LUNG INJURY CAUSED BY CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS MODEL IN RATS

  2009cited by this paper
• HMGB1: Endogenous Danger Signaling

  2008cited by this paper
• Antitumor and antioxidant activity of protocatechualdehyde produced from Streptomyces lincolnensis M-20

  2008cited by this paper
• Role of nuclear factor kappaB in the central nervous system.

  2007cited by this paper
• The Role of Neutrophil-Derived Myeloperoxidase in Organ Dysfunction and Sepsis

  2007cited by this paper
• High mobility group box 1 protein interacts with multiple Toll-like receptors.

  2006cited by this paper
• PNEUMONIA AFTER CECAL LIGATION AND PUNCTURE: A CLINICALLY RELEVANT "TWO-HIT" MODEL OF SEPSIS

  2006cited by this paper
• Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.

  2006cited by this paper
• Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells.

  2005cited by this paper
• RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages

  2005cited by this paper
• Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein*

  2004cited by this paper
• TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.

  2003cited by this paper
• State-of-the-art therapy for severe sepsis and multisystem organ dysfunction.

  2003cited by this paper
• Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality.

  2003cited by this paper
• The enigma of sepsis.

  2003cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1-->3)-beta-D-glucan increases long-term survival in polymicrobial sepsis.

  1999cited by this paper
• Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D -glucan increases long-term survival in polymicrobial sepsis

  1999cited by this paper
• A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

  1997cited by this paper
• Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor).

  1992cited by this paper
• Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

  1982cited by this paper

• Unlocking the therapeutic potential of protocatechualdehyde: pharmacological applications and mechanism insights

  2025cites this paper
• Chemical Recognition and Spectrum‐Effect Relationship of UPLC‐MS Chromatograms With Anti‐Complementary and Antioxidant Activities of Myricariae Ramulus

  2025cites this paper
• Protocatechuic aldehyde restrains NLRP3 inflammasome activation to alleviate inflammatory response in sepsis.

  2025cites this paper
• Cartilage decellularized matrix hydrogel loaded with protocatechualdehyde for targeted epiphycan treatment of osteoarthritis

  2024cites this paper
• Procatechuic acid and protocatechuic aldehyde increase survival of Caenorhabditis elegans after fungal infection and inhibit fungal virulence

  2024cites this paper
• Self-healing hybrid hydrogels with sustained bioactive components release for guided bone regeneration

  2023cites this paper
• Inhibitory effect of protocatechualdehyde on Yersinia enterocolitica and its critical virulence factors.

  2022cites this paper
• Anti-EMT and anti-fibrosis effects of protocatechuic aldehyde in renal proximal tubular cells and the unilateral ureteral obstruction animal model

  2022cites this paper
• Protocatechualdehyde inhibits receptor activator of nuclear factor kappa‐B ligand‐induced osteoclastogenesis and attenuates lipopolysaccharide‐induced inflammatory osteolysis

  2021cites this paper
• Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle

  2021cites this paper
• Xuebijing attenuates decompression-induced lung injuries.

  2020cites this paper
• Cross-Linking Porcine Pericardium by 3,4-Dihydroxybenzaldehyde: A Novel Method to Improve the Biocompatibility of Bioprosthetic Valve.

  2020cites this paper
• 3,4-Dihydroxybenzaldehyde attenuates pentachlorophenol-induced cytotoxicity, DNA damage and collapse of mitochondrial membrane potential in isolated human blood cells

  2020cites this paper
• Fabrication and characterization of a novel collagen-catechol hydrogel

  2018cites this paper
• 3,4-Dihydroxybenzaldehyde quenches ROS and RNS and protects human blood cells from Cr(VI)-induced cytotoxicity and genotoxicity.

  2018cites this paper
• Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics

  2018cites this paper
• Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway

  2018cites this paper
• Effects of Xuebijing Injection for Patients With Sepsis-induced Acute Kidney Injury After Wenchuan Earthquake.

  2017cites this paper
• Protocatechualdehyde Protects Against Cerebral Ischemia-Reperfusion-Induced Oxidative Injury Via Protein Kinase Cε/Nrf2/HO-1 Pathway

  2016cites this paper
• Therapeutic Effect of Protocatechuic Aldehyde in an In Vitro Model of Graves' Orbitopathy.

  2016cites this paper
• In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine

  2016cites this paper
• Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation

  2016cites this paper
• 93: NEW HORIZON IN THE TREATMENT OF SEPSIS: A SYSTEMATIC REVIEW OF ALTERNATIVE MEDICINE

  2016cites this paper
• Bioactivity-integrated UPLC/Q-TOF-MS of Danhong injection to identify NF-κB inhibitors and anti-inflammatory targets based on endothelial cell culture and network pharmacology.

  2015cites this paper
• Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway.

  2015cites this paper
• 8‐O‐Acetyl Shanzhiside Methylester Attenuates Cerebral Ischaemia/Reperfusion Injury through an Anti‐Inflammatory Mechanism in Diabetic Rats

  2014cites this paper
• HMGB1 in health and disease.

  2014cites this paper
• Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease

  2013cites this paper
• Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF.

  2013cites this paper